FDA Commissioner Short List Candidates Have Industry Connections
Executive Summary
The three top candidates on the Bush Administration list to head FDA have significant connections to the drug and biotech industries:
You may also be interested in...
“Regulatory Predictability” Is Key Barrier To Orphan Drug Development, Social Security Head Astrue Says
FDA's new leadership should focus on improving "regulatory predictability" for orphan drug development, Social Security Administration Commissioner Michael Astrue said during a discussion of orphan drug policy sponsored by Shire Pharmaceuticals, the National Chamber Foundation and the U.S. Chamber of Conference in Washington, D.C. June 4
“Regulatory Predictability” Is Key Barrier To Orphan Drug Development, Social Security Head Astrue Says
FDA's new leadership should focus on improving "regulatory predictability" for orphan drug development, Social Security Administration Commissioner Michael Astrue said during a discussion of orphan drug policy sponsored by Shire Pharmaceuticals, the National Chamber Foundation and the U.S. Chamber of Conference in Washington, D.C. June 4
FDA Urged To Improve “Predictability” For Orphan Drugs By Social Security Head Astrue
Commissioner Hamburg urged to set regular briefings on orphan drug development. Policy at the top doesn’t always translate into the “trenches,” former TKT CEO says.